Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: Outcome and prognostic factors

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 2, 2003, Pages 519-528

  Chang, Eric L ^a   Yi, Won ^a   Allen, Pamela K ^a   Levin, Victor A ^a   Sawaya, Raymond E ^a   Maor, Moshe H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Elderly; Glioblastoma; Hypofractionation; Karnofsky performance status; Short course

Indexed keywords

CHEMOTHERAPY; RADIOTHERAPY; TUMORS;

GLIOBLASTOMA PATIENTS;

ONCOLOGY;

BETA INTERFERON; CARMUSTINE; DEXAMETHASONE; EFLORNITHINE; HYDROXYUREA; ISOTRETINOIN; LOMUSTINE; PROCARBAZINE; STEROID; TEMOZOLOMIDE; TIOGUANINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN NECROSIS; CANCER CENTER; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATIENT SELECTION; PERFORMANCE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; STEROID THERAPY; SURVIVAL TIME; TOXICITY; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0038639357     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04522-4     Document Type: Article

References (24)

1. Peschel R.E., Wilson L., Jaffty B., et al. The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. Int J Radiat Oncol Biol Phys. 26:1993;539-544.
2. Halperin EC. Malignant gliomas in older adults with poor prognostic signs. Oncology 1995;9:229-234.
3. Villa S., Vinolas N., Verger E., et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys. 42:1998;977-980.
4. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 5:1979;1725-1731.
5. Kleinberg L., Slick T., Enger C., et al. Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys. 38:1997;31-36.
6. Bauman G.S., Gaspar L.E., Fisher B.J., et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 4:1994;835-839.
7. Hercbergs A.A., Tadmor R., Findler G., et al. Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Cancer. 64:1989;816-820.
8. Hulshof M.C.C.M., Schimmel E.C., Bosch D.A., et al. Hypofractionation in glioblastoma multiforme. Radiother Oncol. 54:2002;143-148.
9. Lantos PL, Bruner JM. Gliomatosis cerebr: In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumors of the nervous system. Lyon: IARC Press; 2000. p. 92.
10. Curran W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 85:1993;704-710.
11. Kaplan-Meier E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Hernandez J.C., Maruyama Y., Yaes R., et al. Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors. J Neurooncol. 9:1990;41-45.
13. Thomas R., James N., Guerrero D., et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol. 33:1994;113-116.
14. Tamura M., Nakamura M., Kunimine H., et al. Large dose fraction radiotherapy in the treatment of glioblastoma. J Neurooncol. 7:1989;113-119.
15. Newall J., Ranshoff J., Kaplan B. Glioblastoma in the older patients How long a course of radiotherapy is necessary? J Neurooncol. 6:1988;325-327.
16. Slotman B.J., Kralendonk J.H., August H.M., et al. Hypofractionated radiation therapy in patients with glioblastoma multiforme Results of treatment and impact of prognostic factors . Int J Radiat Oncol Biol Phys. 34:1996;895-898.
17. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
18. Mohan D.S., Suh J.H., Phan J.L., et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys. 42:1998;981-987.
19. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme Prognosis, extent of resection, and survival . J Neurosurg. 95:2001;190-198.
20. Kelly P.J., Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 34:1994;62-67.
21. Winger M.J., MacDonald D.R., Cairncross J.G. Supratentorial anaplastic gliomas in adults. J Neurosurg. 71:1989;487-493.
22. Levin V.A., Prados M.R., Wara W.M., et al. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys. 32:1995;75-83.
23. Yung W.K., Albright R.E., Olson J., et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer. 83:2000;588-593.
24. Fine H.A., Dear K.B., Loeffler J.S., et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 71:1993;2585-2597.